Press release
Oxycodone Drugs Market Size to Witness Huge Growth by 2032 -Acura Pharmaceuticals, Alvogen, Amneal Pharmaceuticals LLC. , Ascent Pharmaceuticals, Inc.
With a compound annual growth rate (CAGR) of 5.4%, the global oxycodone drugs market is expected to reach a value of over USD 8.29 billion by 2032 from an estimated USD 5.19 billion in 2023.Oxycodone is an opioid medicine utilized to cure average to crucial pain when alternate pain therapies do not function well enough. It assists in decreasing pain by operating opioid receptors in the nervous system as it is an opioid lead. It can be utilized as a solitary component pain adjunct and is also obtainable in amalgamation with acetaminophen. It is a regulated matter Schedule II which indicates that it has an acquired medical usage but may create grave psychological or tangible reliance and has an excessive probability for misuse.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ ๐๐๐ญ๐จ๐ซ๐ฌ:
โข The oxycodone industry is expected to witness significant prospects due to the escalating weight of detrimental illnesses such as cancer, rheumatoid arthritis, lower back pain, & fibromyalgia.
โข Opioid medicines have acquired notable approval amongst healthcare experts due to their capacity to manage chronic pain. This has energized the manufacturers to escalate the R&D costs for their oxycodone drugs. For instance, as per the yearly report 2022, the advertising and product advancement prices of Collegium Pharmaceutical escalated to USD 11,743.0 in 2022, from USD 4,186.0 in 2021.
๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐๐๐จ๐ฉ๐ญ๐๐ ๐๐ฒ ๐๐๐๐๐ข๐ง๐ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
The market contention is fierce due to the imposing of many prominent players. A list of key companies profiled in the oxycodone drugs market are:
โข Acura Pharmaceuticals (U.S.)
โข Alvogen (U.S.)
โข Amneal Pharmaceuticals LLC. (U.S.)
โข Ascent Pharmaceuticals, Inc. (U.S.)
โข Collegium Pharmaceutical (U.S.)
โข Endo International plc (Ireland)
โข Epic Pharma, LLC. (U.S.)
โข Mallinckrodt (Ireland)
โข Mundipharma International (UK)
โข Pfizer Inc. (U.S.)
โข Protega Pharmaceuticals Inc. (U.S.)
โข Rhodes Pharmaceuticals L.P. (U.S.)
โข Sun Pharmaceutical Industries Ltd. (India)
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/3295/2
๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐๐ฅ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The regions covered in the report are Europe, North America, Asia Pacific, Middle East & Africa, and Latin America. Also, according to a study, Asia Pacific held the largest oxycodone market share. This is essentially due to the growing aggregate of surgical processes, the growing requirement of oxycodone for grave post-surgical care, and the escalating weight of detrimental pain illnesses.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ซ๐๐๐ค๐๐จ๐ฐ๐ง:
๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฒ๐ฉ๐:
โข Short-acting
โข Long-acting
๐๐ฒ ๐๐จ๐ฌ๐๐ ๐ ๐ ๐จ๐ซ๐ฆ:
โข Tablet
โข Capsule
โข Injection
๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ:
โข Hospital Pharmacy
โข Retail Pharmacy
โข Online Pharmacy
๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐ ๐ญ๐จ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
๐๐ฎ๐ฌ๐ญ๐ซ๐๐ฅ๐ข๐ ๐ ๐๐๐ข๐๐ฅ ๐๐ง๐ฃ๐๐๐ญ๐๐๐ฅ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ:
https://www.polarismarketresearch.com/industry-analysis/australia-facial-injectable-market
๐ ๐ข๐๐ซ๐๐ญ๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ:
https://www.polarismarketresearch.com/industry-analysis/fibrate-drugs-market
๐๐๐ซ๐ฉ๐๐ฌ ๐๐ข๐ฆ๐ฉ๐ฅ๐๐ฑ ๐๐ข๐ซ๐ฎ๐ฌ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ:
https://www.polarismarketresearch.com/industry-analysis/herpes-simplex-virus-treatment-market
๐๐ข๐ฉ๐ข๐ ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ:
https://www.polarismarketresearch.com/industry-analysis/lipid-regulators-market
๐๐ฅ๐๐ฑ๐ข๐ฉ๐ก๐๐ซ๐ฆ๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ:
https://www.polarismarketresearch.com/industry-analysis/alexipharmic-drugs-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ง๐๐จ:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oxycodone Drugs Market Size to Witness Huge Growth by 2032 -Acura Pharmaceuticals, Alvogen, Amneal Pharmaceuticals LLC. , Ascent Pharmaceuticals, Inc. here
News-ID: 3617217 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expan โฆ
The global mobile biometrics market is projected to be valued at approximately USD 53.10 billion in 2025 and is expected to witness strong growth through 2034, driven by rising concerns over data security, increasing smartphone-based digital transactions, and the growing adoption of biometric authentication across banking, enterprise, and government sectors. The market is anticipated to expand at a CAGR of 19.88% during the forecast period, reaching an estimated value ofโฆ
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During โฆ
Polaris Market Research recently introduced the latest update on Bioregenerative Aesthetic Injectables Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Bioregenerative Aesthetic Injectables Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast.
The report helps businesses get a thorough understanding of theโฆ
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a โฆ
Global Copper Mining Market is currently valued at USD 191.96 Billion in 2025 and is anticipated to generate an estimated revenue of USD 235.28 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.29% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034
Polaris Market Research has introduced the latest market research report titled Copperโฆ
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, โฆ
Global Specialty Oilfield Chemicals Market is currently valued at USD 11.0 Billion in 2025 and is anticipated to generate an estimated revenue of USD 16.7 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034
Polaris Market Research has introduced the latest market research report titledโฆ
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten โฆ
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailedโฆ
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva โฆ
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand theโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoringโฆ
